Risk for hyperkalaemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the GFR;Hyperkaliämierisiko unter langzeittherapie mit ACE-hemmern bei insulinpflichtigen typ-2-diabetikern in abhängigkeit von der GFR

Deutsche Medizinische Wochenschrift

Volumn 126, Issue 47, 2001, Pages 1327-1330

  Raml, A ^a   Schmekal, B ^a   Grafinger, P ^a   Biesenbach, G ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CAPTOPRIL; CILAZAPRIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; HEMOGLOBIN A1C; INSULIN; POTASSIUM; RAMIPRIL;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN DETERMINATION; HUMAN; HYPERKALEMIA; HYPOALDOSTERONISM; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; MALE; METABOLIC REGULATION; POTASSIUM BLOOD LEVEL; PROTEINURIA; RISK ASSESSMENT;

AGED; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERKALEMIA; HYPOALDOSTERONISM; INSULIN; MALE; MIDDLE AGED; POTASSIUM; RISK FACTORS;

EID: 0035941136     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18569     Document Type: Article

References (17)

1. Predictors of the development of Hyperkalemia in patients using angiotensin-converting enzyme inhibitors
2. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: Is this a cause for concern?
3. Rapid life-threatening Hyperkalemia after addition of amiloride HCl/hydrochlorothiazide to angiotensin-converting enzyme inhibitor therapy
4. Life-threatening Hyperkalemia associated with captopril administration
5. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
6. Which drugs affect potassium
7. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
8. A subdepressor low dose dose of ramipril lowers urinary protein excretion without increasing plasma potassium
9. Behandlungsqualität niereninsuffizienter diabetiker in Deutschland
10. Enalapril in the treatment of hypertension associated with renal failure: Results from a multicenter study
11. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy
12. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus
13. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry?
14. Angiotensin-converting-enzym-hemmer bei der behandlung der diabetischen Nephropathie
15. Isolated hypoaldosteronism in adults
16. Long-term reno-protective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy
17. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril